Use of sclerosing agent in the management of oral and perioral hemangiomas: review and case reports.
BACKGROUND
Most cutaneous hemangiomas involute spontaneously. However, the lesion existing on the face poses a cosmetic problem while waiting for involution.


METHODS
Three hemangioma cases were treated by repeated local injection of 5% ethanolamine oleate solution. The lesions flattened and markedly reduced in size as shown by clinical and imaging evaluation.


CONCLUSIONS
Use of 5% ethanolamine oleate as a sclerosing agent for repeated intralesional injection in the management of facial hemangiomas is a safe treatment with acceptable results. As presented here, this technique offers the patient considerable relief of symptoms with minimal complications. However, the possibility of second-stage surgery to correct residual deformity is still considered. Sclerotherapy with ethanolamine oleate provides a good preparation for further surgery.
Selim
Heba
H
Faculty of Dentistry, Oral and Maxillofacial Surgery, Ain-Shams University, Cairo, Egypt.
Selim
Abdulhafez
A
Khachemoune
Amor
A
Metwally
Salah Abdel Fattah A
SA
D000293:Adolescent; D014408:Biomarkers, Tumor / Q000378:metabolism; D005260:Female; D006391:Hemangioma / Q000098:blood supply / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D007150:Immunohistochemistry; D007223:Infant; D009062:Mouth Neoplasms / Q000098:blood supply / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology*; D012597:Sclerosing Solutions / Q000627:therapeutic use*; D015911:Sclerotherapy; D015898:Tomography Scanners, X-Ray Computed
D014408:Biomarkers, Tumor; D012597:Sclerosing Solutions